Barrington Research analyst Vincent Colicchio reiterates Concentrix (NASDAQ:CNXC) with a Outperform and maintains $165 price target.
Barrington Research Reiterates Outperform on Concentrix, Maintains $165 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.